Bortezomib Injection, Powder, Lyophilized, For Solution
Product Images NDC 25021-262

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Bortezomib (NDC 25021-262). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Bor06 0000 01)

Chemical Structure (Bor06 0000 01)
FDA Label Image

Figure 1 (Bor06 0000 02)

Figure 1 (Bor06 0000 02)
FDA Label Image

Figure 2 (Bor06 0000 03)

Figure 2 (Bor06 0000 03)
FDA Label Image

Figure 3 (Bor06 0000 04)

Figure 3 (Bor06 0000 04)
FDA Label Image

Figure 4 (Bor06 0000 05)

Figure 4 (Bor06 0000 05)
FDA Label Image

Figure 5 (Bor06 0000 06)

Figure 5 (Bor06 0000 06)
FDA Label Image

Figure 6 (Bor06 0000 07)

Figure 6 (Bor06 0000 07)
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Bor06 0000 08)

Package Label – Principal Display Panel – Vial Label (Bor06 0000 08)